Selway Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $874K | Hold |
14,331
| – | – | 0.36% | 52 |
|
2024
Q4 | $811K | Sell |
14,331
-1,500
| -9% | -$84.8K | 0.32% | 54 |
|
2024
Q3 | $819K | Sell |
15,831
-21,100
| -57% | -$1.09M | 0.32% | 54 |
|
2024
Q2 | $1.53M | Sell |
36,931
-3,035
| -8% | -$126K | 0.63% | 45 |
|
2024
Q1 | $2.17M | Sell |
39,966
-1,100
| -3% | -$59.7K | 0.87% | 37 |
|
2023
Q4 | $2.11M | Sell |
41,066
-5,468
| -12% | -$281K | 0.89% | 36 |
|
2023
Q3 | $2.7M | Sell |
46,534
-2,780
| -6% | -$161K | 1.24% | 28 |
|
2023
Q2 | $3.15M | Buy |
49,314
+60
| +0.1% | +$3.84K | 1.38% | 27 |
|
2023
Q1 | $3.41M | Buy |
49,254
+4,000
| +9% | +$277K | 1.64% | 23 |
|
2022
Q4 | $3.26M | Sell |
45,254
-585
| -1% | -$42.1K | 1.72% | 22 |
|
2022
Q3 | $3.26M | Sell |
45,839
-131
| -0.3% | -$9.31K | 1.9% | 17 |
|
2022
Q2 | $3.54M | Buy |
45,970
+500
| +1% | +$38.5K | 1.96% | 15 |
|
2022
Q1 | $3.32M | Sell |
45,470
-3,300
| -7% | -$241K | 1.61% | 21 |
|
2021
Q4 | $3.04M | Sell |
48,770
-200
| -0.4% | -$12.5K | 1.44% | 25 |
|
2021
Q3 | $2.9M | Buy |
48,970
+275
| +0.6% | +$16.3K | 1.58% | 23 |
|
2021
Q2 | $3.25M | Buy |
48,695
+2,050
| +4% | +$137K | 1.74% | 20 |
|
2021
Q1 | $2.95M | Buy |
46,645
+4,075
| +10% | +$257K | 1.71% | 17 |
|
2020
Q4 | $2.64M | Buy |
42,570
+800
| +2% | +$49.6K | 1.61% | 20 |
|
2020
Q3 | $2.52M | Buy |
41,770
+9,300
| +29% | +$561K | 1.78% | 20 |
|
2020
Q2 | $1.91M | Buy |
32,470
+125
| +0.4% | +$7.35K | 1.52% | 24 |
|
2020
Q1 | $1.8M | Buy |
32,345
+850
| +3% | +$47.4K | 1.74% | 21 |
|
2019
Q4 | $2.02M | Buy |
+31,495
| New | +$2.02M | 1.39% | 24 |
|